TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,912 | -65.9% | 15,779 | -38.7% | 0.04% | -69.0% |
Q1 2023 | $387,069 | +62.6% | 25,736 | +53.8% | 0.13% | +117.2% |
Q1 2018 | $238,000 | +52.6% | 16,738 | +8.0% | 0.06% | +7.4% |
Q2 2017 | $156,000 | +81.4% | 15,500 | -16.7% | 0.05% | +20.0% |
Q4 2016 | $86,000 | – | 18,600 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |